OMP Plus brings End-to-End Supply Chain Visibility to Allergopharma

September 20, 2018

The Allergopharma GmbH & Co. KG, a biopharmaceutical company focused on allergy treatments, recently implemented OMP Plus as supply chain planning system of record, to support its centralized Global Supply Chain organization. The solution covers all levels of a complex multi-level supply chain, extending from raw materials to finished products. Additionally, the solution creates value by integrating related business functions, including Regulatory Affairs and QA/QC.

The key business driver for this project was to establish an integrated and future proof supply chain management capability. With a planning horizonof 3 years, Allergopharma can now meet demand and supply in the most efficient way, effectively manage launches and further shorten planning and execution cycles. Attribute-based planning is the main enabler for this integrated biopharma planning. OMP Plus pegs all supply chain levels together while still respecting constraints, such as keeping the same bulk origin for packs of multiple dosage types or country-specific minimum remaining shelf life constraints.

Pascal Sainte Cluque, Director Global Supply Planning at Allergopharma: “Our planning cycle used to take 3 months for any replanning. Thanks to OMP Plus, a smaller team managed to achieve a reduction of the planning cycle to less than 1 day. This reduction offers us great benefits like quick scenario planning, lower inventory levels and improved service levels, as we can react quickly in case of, for example, off-spec batches.

Dirk van Ginderachter, Associate Director at OM Partners: “This project confirms OMP Plus’ strong capability not only in terms of providing full visibility of a complex supply chain, but also in terms of addressing important and complex constraints in the biopharmaceutical industry. We are proud to deliver business value by improving crucial commercial and supply chain KPIs.”

About Allergopharma

The Allergopharma GmbH & Co. KG is a leading player in the allergen immunotherapy (AIT) of type I allergies, such as hay fever or allergic asthma. The product range encompasses a diverse spectrum of approved allergen preparations, which correspond to the highest quality standards. The products of Allergopharma are available in more than 18 countries worldwide.